Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

Pathological analysis of the nuclear proliferation biomarker Ki67 has multiple potential roles in breast and other cancers. However, clinical utility of the immunohistochemical (IHC) assay for Ki67 immunohistochemistry has been hampered by unacceptable between-laboratory analytical variability. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Samuel C Y, Nielsen, Torsten O, Zabaglo, Lila, Arun, Indu, Badve, Sunil S, Bane, Anita L, Bartlett, John M S, Borgquist, Signe, Chang, Martin C, Dodson, Andrew, Enos, Rebecca A, Fineberg, Susan, Focke, Cornelia M, Gao, Dongxia, Gown, Allen M, Grabau, Dorthe, Gutierrez, Carolina, Hugh, Judith C, Kos, Zuzana, Lænkholm, Anne-Vibeke, Lin, Ming-Gang, Mastropasqua, Mauro G, Moriya, Takuya, Nofech-Mozes, Sharon, Osborne, C Kent, Penault-Llorca, Frédérique M, Piper, Tammy, Sakatani, Takashi, Salgado, Roberto, Starczynski, Jane, Viale, Giuseppe, Hayes, Daniel F, McShane, Lisa M, Dowsett, Mitch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515324/
https://www.ncbi.nlm.nih.gov/pubmed/28721378
http://dx.doi.org/10.1038/npjbcancer.2016.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515324/
https://www.ncbi.nlm.nih.gov/pubmed/28721378
http://dx.doi.org/10.1038/npjbcancer.2016.14

Ejemplares similares